Trocprofit, jmo but I don't think we see anything at SNO on dcvax. Lots of good research to be presented just not what we are waiting on. Check out the post from biosect #415425 - seems a very plausible reason on the timing to me
After a certain point you have to be willing to walk away, especially if someone is being passive aggressive and not really interested in moving forward on a time table that works for shareholders. I think that if they did not have a date certain for publication after a year (this is more than fair of TLD is really so great and we’re really giving that journal a huge scoop) then moving forward to SNO is crucial because otherwise we would be at their mercy until ASCO. Now would be the time to jump ship.
Still, I expect NWBO to waste time and not to do the peer review with SNO. While Flipper has presented some tantalizing hints I seriously doubt those breadcrumbs mean anything.